193 related articles for article (PubMed ID: 24080507)
1. Mortality and use of the auxiliary score in extensive toxic epidermal necrolysis patients admitted to an adult burns referral centre.
Mahar PD; Wasiak J; Cleland H; Watters D; Paul E; Marsh P; Gin D
Dermatology; 2013; 227(2):180-5. PubMed ID: 24080507
[TBL] [Abstract][Full Text] [Related]
2. Improving mortality outcomes of Stevens Johnson syndrome/toxic epidermal necrolysis: A regional burns centre experience.
Nizamoglu M; Ward JA; Frew Q; Gerrish H; Martin N; Shaw A; Barnes D; Shelly O; Philp B; El-Muttardi N; Dziewulski P
Burns; 2018 May; 44(3):603-611. PubMed ID: 29029855
[TBL] [Abstract][Full Text] [Related]
3. Comparing mortality outcomes of major burns and toxic epidermal necrolysis in a tertiary burns centre.
Mahar PD; Wasiak J; Paul E; Watters DA; Kirby J; Gin D; Marsh P; Cleland H
Burns; 2014 Dec; 40(8):1743-7. PubMed ID: 24814156
[TBL] [Abstract][Full Text] [Related]
4. 27 years of a single burn centre experience with Stevens-Johnson syndrome and toxic epidermal necrolysis: analysis of mortality risk for causative agents.
Weinand C; Xu W; Perbix W; Lefering R; Maegele M; Rathert M; Spilker G
Burns; 2013 Nov; 39(7):1449-55. PubMed ID: 23702222
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology and costs of patients with toxic epidermal necrolysis: a 27-year retrospective study.
Oen IM; van der Vlies CH; Roeleveld YW; Dokter J; Hop MJ; van Baar ME
J Eur Acad Dermatol Venereol; 2015 Dec; 29(12):2444-50. PubMed ID: 26416341
[TBL] [Abstract][Full Text] [Related]
6. Ophthalmic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Relation to SCORTEN.
Morales ME; Purdue GF; Verity SM; Arnoldo BD; Blomquist PH
Am J Ophthalmol; 2010 Oct; 150(4):505-510.e1. PubMed ID: 20619392
[TBL] [Abstract][Full Text] [Related]
7. Nine years of a single referral center management of Stevens-Johnson syndrome and toxic epidermal necrolysis (Lyell's syndrome).
Monteiro D; Egipto P; Barbosa J; Horta R; Amarante J; Silva P; Silva A
Cutan Ocul Toxicol; 2017 Jun; 36(2):163-168. PubMed ID: 27487073
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of histologic features of toxic epidermal necrolysis.
Valeyrie-Allanore L; Bastuji-Garin S; Guégan S; Ortonne N; Bagot M; Roujeau JC; Revuz JE; Wechsler J; Wolkenstein P
J Am Acad Dermatol; 2013 Feb; 68(2):e29-35. PubMed ID: 22088428
[TBL] [Abstract][Full Text] [Related]
9. Acute blistering diseases on the burn ward: Beyond Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
Richer V; Bouffard D; Bélisle A; Duranceau L; Perreault I; Provost N
Burns; 2013 Sep; 39(6):1290-6. PubMed ID: 23597847
[TBL] [Abstract][Full Text] [Related]
10. SCORTEN: a severity-of-illness score for toxic epidermal necrolysis.
Bastuji-Garin S; Fouchard N; Bertocchi M; Roujeau JC; Revuz J; Wolkenstein P
J Invest Dermatol; 2000 Aug; 115(2):149-53. PubMed ID: 10951229
[TBL] [Abstract][Full Text] [Related]
11. SCORTEN accurately predicts mortality among toxic epidermal necrolysis patients treated in a burn center.
Cartotto R; Mayich M; Nickerson D; Gomez M
J Burn Care Res; 2008; 29(1):141-6. PubMed ID: 18182912
[TBL] [Abstract][Full Text] [Related]
12. Toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS): experience with high-dose intravenous immunoglobulins and topical conservative approach. A retrospective analysis.
Stella M; Clemente A; Bollero D; Risso D; Dalmasso P
Burns; 2007 Jun; 33(4):452-9. PubMed ID: 17475410
[TBL] [Abstract][Full Text] [Related]
13. Examining triage patterns of inhalation injury and toxic epidermal necrolysis-Stevens Johnson syndrome.
Davis JS; Pandya RK; Pizano LR; Namias N; Dearwater S; Schulman CI
J Burn Care Res; 2013; 34(5):492-7. PubMed ID: 23966120
[TBL] [Abstract][Full Text] [Related]
14. Toxic epidermal necrolysis: five years of treatment experience from a burn unit.
Firoz BF; Henning JS; Zarzabal LA; Pollock BH
J Am Acad Dermatol; 2012 Oct; 67(4):630-5. PubMed ID: 22285617
[TBL] [Abstract][Full Text] [Related]
15. A decade of burn unit experience with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: Clinical pathological diagnosis and risk factor awareness.
Lim VM; Do A; Berger TG; Nguyen AH; DeWeese J; Malone JD; Jordan K; Hom F; Tuffanelli L; Fillari P; Siu S; Grossman R
Burns; 2016 Jun; 42(4):836-43. PubMed ID: 26847613
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporine treatment for Stevens-Johnson syndrome/toxic epidermal necrolysis: Retrospective analysis of a cohort treated in a specialized referral center.
Lee HY; Fook-Chong S; Koh HY; Thirumoorthy T; Pang SM
J Am Acad Dermatol; 2017 Jan; 76(1):106-113. PubMed ID: 27717620
[TBL] [Abstract][Full Text] [Related]
17. Hospital management and clinical factors associated with ophthalmic involvement in toxic epidermal necrolysis.
Hii BW; Mahar PD; Wasiak J; Hall AJ; Paul E; Marsh P; Buck DA; Cleland H
Burns; 2014 Aug; 40(5):903-8. PubMed ID: 24286611
[TBL] [Abstract][Full Text] [Related]
18. Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: a retrospective comparative study in China.
Yang Y; Xu J; Li F; Zhu X
Int J Dermatol; 2009 Oct; 48(10):1122-8. PubMed ID: 19775409
[TBL] [Abstract][Full Text] [Related]
19. The role of intravenous immunoglobulin in toxic epidermal necrolysis: a retrospective analysis of 64 patients managed in a specialized centre.
Lee HY; Lim YL; Thirumoorthy T; Pang SM
Br J Dermatol; 2013 Dec; 169(6):1304-9. PubMed ID: 24007192
[TBL] [Abstract][Full Text] [Related]
20. Steven Johnson Syndrome and Toxic Epidermal Necrolysis in a burn unit: A 15-year experience.
McCullough M; Burg M; Lin E; Peng D; Garner W
Burns; 2017 Feb; 43(1):200-205. PubMed ID: 27554629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
